EQ5D-5L scores in men undergoing radiation therapy for prostate cancer using a 1.5 MR Linac Included in the MOMENTUM (NCT04075305) prospective multi institutional trial
Schottstaedt, A. M. Daamen, L. A. vanzyp, J. V. Choi, S. Teunissen, F. R. Tree, A. van der Heide, U. Lawton, C. A. F. Christodouleas, J.
Schottstaedt, A. M.
Daamen, L. A.
vanzyp, J. V.
Choi, S.
Teunissen, F. R.
Tree, A.
van der Heide, U.
Lawton, C. A. F.
Christodouleas, J.
Citations
Altmetric:
Abstract
Description
Date
2022
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Schottstaedt AM, Daamen LA, vanzyp JV, Choi S, Choudhury A, Teunissen FR, et al. EQ5D-5L Scores in Men Undergoing Radiation Therapy for Prostate Cancer Using a 1.5 MR Linac Included in the MOMENTUM (NCT04075305) Prospective Multi Institutional Trial. International Journal of Radiation Oncology Biology Physics. 2022 Nov;114(3):E454-E5. PubMed PMID: WOS:000892639301338.